Cargando…
Update on biomarkers in neuromyelitis optica
Neuromyelitis optica (NMO) (and NMO spectrum disorder) is an autoimmune inflammatory disease of the CNS primarily affecting spinal cord and optic nerves. Reliable and sensitive biomarkers for onset, relapse, and progression in NMO are urgently needed because of the heterogeneous clinical presentatio...
Autores principales: | Melamed, Esther, Levy, Michael, Waters, Patrick J., Sato, Douglas Kazutoshi, Bennett, Jeffrey L., John, Gareth R., Hooper, Douglas C., Saiz, Albert, Bar-Or, Amit, Kim, Ho Jin, Pandit, Lakha, Leite, Maria Isabel, Asgari, Nasrin, Kissani, Najib, Hintzen, Rogier, Marignier, Romain, Jarius, Sven, Marcelletti, John, Smith, Terry J., Yeaman, Michael R., Han, May H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516398/ https://www.ncbi.nlm.nih.gov/pubmed/26236760 http://dx.doi.org/10.1212/NXI.0000000000000134 |
Ejemplares similares
-
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
por: Hor, Jyh Yung, et al.
Publicado: (2020) -
The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013) -
B lymphocytes in neuromyelitis optica
por: Bennett, Jeffrey L., et al.
Publicado: (2015) -
Interferon Alpha Association with Neuromyelitis Optica
por: Asgari, Nasrin, et al.
Publicado: (2013) -
Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Schanda, Kathrin, et al.
Publicado: (2015)